Therapeutic Indications

Celiprolol is indicated for:

Mild to moderate hypertension

Irrespective of gender only Adults (18 years old or older)

Celiprolol is indicated for the treatment of mild to moderate hypertension.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 200-400 mg once daily

Contraindications

Active ingredient Celiprolol is contraindicated in the following cases:

Severe renal impairment (creatinine clearance <15 ml per minute)

No gender/age discrimination

Theophylline

No gender/age discrimination

Celiprolol should not be prescribed for patients being treated with theophylline.

Second degree heart block

No gender/age discrimination

Decompensated cardiac failure

No gender/age discrimination

Uncontrolled heart failure.

Raynaud's syndrome

No gender/age discrimination

Asthma

No gender/age discrimination

Acute episodes of asthma.

Third degree atrioventricular block

No gender/age discrimination

Phaeochromocytoma

No gender/age discrimination

Untreated phaeochromocytoma.

Celiprolol should be used with caution in patients with treated phaeochromocytoma and must not be adminstered until after alpha-blockade has been established. Close monitoring is advisable.

Severe chronic obstructive pulmonary disease

No gender/age discrimination

Sick sinus syndrome

No gender/age discrimination

Peripheral arterial occlusive disease

No gender/age discrimination

Severe peripheral arterial circulatory disturbances.

Hypotension

No gender/age discrimination

Bradycardia (<45–50 beats per minute)

No gender/age discrimination

Metabolic acidosis

No gender/age discrimination

Sinoatrial block

No gender/age discrimination

Cardiogenic shock

No gender/age discrimination